{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T12:34:29Z","timestamp":1766752469007,"version":"3.48.0"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer-related movement disorders (CRMDs) comprise a diverse group of neurological complications of cancer. They result from varied etiologies and can be associated with compromised quality of life and poor prognosis. CRMDs can be divided into two broad categories: movement disorders resulting from cancer-related processes, such as direct tumor infiltration and paraneoplastic disease, and those that are a consequence of cancer-directed treatments, including classic therapies, such as chemotherapy and radiation therapy, novel treatments (eg immunotherapies and CAR T-Cell therapies), and various supportive treatments. A clear understanding of the breadth of CRMDs is vital, as effective management relies upon accurately identifying their underlying etiology. In this scoping review, we provide a comprehensive categorization of CRMDs based on their underlying etiology and phenomenology. Additionally, we propose a structured framework to guide the diagnostic evaluation and management of CRMDs, with the goal of facilitating timely diagnosis and, ultimately, improved patient outcomes.<\/jats:p>","DOI":"10.1093\/nop\/npaf062","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T07:31:47Z","timestamp":1749972707000},"page":"970-982","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-related movement disorders: A scoping review and diagnostic approach"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0971-1482","authenticated-orcid":false,"given":"Laura E","family":"Schroeder","sequence":"first","affiliation":[{"name":"The Neurology Department, Alpert Medical School of Brown University , Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Snow","sequence":"additional","affiliation":[{"name":"The Neurology Department, Alpert Medical School of Brown University , Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casandra","family":"Chen","sequence":"additional","affiliation":[{"name":"The Neurology Department, Alpert Medical School of Brown University , Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Addo","sequence":"additional","affiliation":[{"name":"The Neurology Department, Alpert Medical School of Brown University , Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Mohammadzadeh","sequence":"additional","affiliation":[{"name":"The Neurology Department, Alpert Medical School of Brown University , Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Recht","sequence":"additional","affiliation":[{"name":"The Neurology and Neurological Sciences Department, Stanford School of Medicine , Stanford, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saud","family":"Alhusaini","sequence":"additional","affiliation":[{"name":"The Neurology Department, Alpert Medical School of Brown University , Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"2 Neuro-oncology","key":"2025122607315098300_CIT0001","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1212\/01.CON.0000464179.81957.51","article-title":"Neurologic complications of chemotherapy and radiation therapy","volume":"21","author":"Nolan","year":"2015","journal-title":"Continuum (Minneapolis, Minn.)"},{"key":"2025122607315098300_CIT0002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","article-title":"Autoimmune and paraneoplastic movement disorders: an update","volume":"385","author":"Baizabal-Carvallo","year":"2018","journal-title":"J Neurol Sci."},{"issue":"6","key":"2025122607315098300_CIT0003","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/CON.0000000000000943","article-title":"Neurotoxicity of cancer therapies","volume":"26","author":"Dietrich","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"2025122607315098300_CIT0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14802\/jmd.22092","article-title":"Movement disorders associated with radiotherapy and surgical procedures","volume":"16","author":"Surisetti","year":"2023","journal-title":"J Mov Disord"},{"issue":"11","key":"2025122607315098300_CIT0005","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/brainsci11111414","article-title":"Update on paraneoplastic cerebellar degeneration","volume":"11","author":"Loehrer","year":"2021","journal-title":"Brain Sci"},{"issue":"10","key":"2025122607315098300_CIT0006","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/jnnp.56.10.1113","article-title":"Evaluation of the effect of treatment on movement disorders in astrocytomas of the basal ganglia and the thalamus","volume":"56","author":"Krauss","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"5","key":"2025122607315098300_CIT0007","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/mdc3.14003","article-title":"Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors","volume":"11","author":"Dinoto","year":"2024","journal-title":"Mov Disord Clin Pract"},{"issue":"10423","key":"2025122607315098300_CIT0008","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet."},{"issue":"8","key":"2025122607315098300_CIT0009","first-page":"405","article-title":"Thalamic tumors: clinical presentation","volume":"18","author":"Mart\u00ednez-Lage","year":"2002","journal-title":"Childs Nerv Syst."},{"issue":"3","key":"2025122607315098300_CIT0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1620\/tjem.220.187","article-title":"Cerebral infratentorial large B-cell lymphoma presenting as Parkinsonism","volume":"220","author":"Lin","year":"2010","journal-title":"Tohoku J Exp Med."},{"issue":"12","key":"2025122607315098300_CIT0011","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/jnnp.55.12.1162","article-title":"Movement disorders in astrocytomas of the basal ganglia and the thalamus","volume":"55","author":"Krauss","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"2025122607315098300_CIT0012","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10072-020-04985-3","article-title":"Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature","volume":"42","author":"Grillo","year":"2021","journal-title":"Neurol Sci."},{"issue":"1","key":"2025122607315098300_CIT0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000070859","article-title":"Reversible choreoathetosis in primary cerebral lymphoma: clinicoradiologic correlation","volume":"50","author":"Tan","year":"2003","journal-title":"Eur Neurol."},{"issue":"4","key":"2025122607315098300_CIT0014","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/NRL.0b013e31816c43ea","article-title":"Hemiparkinsonism secondary to an infiltrative astrocytoma","volume":"14","author":"Ho","year":"2008","journal-title":"Neurologist"},{"issue":"5","key":"2025122607315098300_CIT0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8257(199909)14:5<842::AID-MDS1020>3.0.CO;2-O","article-title":"Parkinsonism in children resulting from mesencephalic tumors","volume":"14","author":"Pohle","year":"1999","journal-title":"Mov Disord."},{"issue":"2","key":"2025122607315098300_CIT0016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14802\/jmd.16005","article-title":"Movement disorders following cerebrovascular lesion in the Basal Ganglia Circuit","volume":"9","author":"Park","year":"2016","journal-title":"J Mov Disord"},{"issue":"5","key":"2025122607315098300_CIT0017","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neurol.2023.03.009","article-title":"Stroke and cancer","volume":"179","author":"Zuber","year":"2023","journal-title":"Rev Neurol (Paris)."},{"issue":"5","key":"2025122607315098300_CIT0018","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/mds.870090502","article-title":"Movement disorders following lesions of the thalamus or subthalamic region","volume":"9","author":"Lee","year":"1994","journal-title":"Movement Disord"},{"issue":"3","key":"2025122607315098300_CIT0019","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1531-8257(199905)14:3<497::AID-MDS1019>3.0.CO;2-X","article-title":"Hemichorea and hemiballism associated with contralateral hemiparesis and ipsilateral basal ganglia lesions","volume":"14","author":"Krauss","year":"1999","journal-title":"Mov Disord."},{"issue":"3","key":"2025122607315098300_CIT0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/0004-282x20190020","article-title":"Acute cerebellar ataxia: differential diagnosis and clinical approach","volume":"77","author":"Pedroso","year":"2019","journal-title":"Arq Neuropsiquiatr."},{"issue":"5","key":"2025122607315098300_CIT0021","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jocn.2014.11.013","article-title":"Steroid-responsive intracranial germinoma presenting as Holmes\u2019 tremor: importance of a tissue diagnosis","volume":"22","author":"Strowd","year":"2015","journal-title":"J Clin Neurosci."},{"key":"2025122607315098300_CIT0022","doi-asserted-by":"crossref","first-page":"bcr2013009438","DOI":"10.1136\/bcr-2013-009438","article-title":"Palatal tremor in relation to brainstem tumour involvement","volume":"2013","author":"Marques","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2025122607315098300_CIT0023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/biomedicines10010026","article-title":"Movement disorders in oncology: from clinical features to biomarkers","volume":"10","author":"Marsili","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"2025122607315098300_CIT0024","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11910-013-0346-3","article-title":"Brainstem glioma: a review","volume":"13","author":"Grimm","year":"2013","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"12","key":"2025122607315098300_CIT0025","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s00415-013-7096-7","article-title":"Cortical hemichorea-hemiballism","volume":"260","author":"Hwang","year":"2013","journal-title":"J Neurol."},{"issue":"3","key":"2025122607315098300_CIT0026","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jnnp.72.3.329","article-title":"Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT","volume":"72","author":"Kim","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"2025122607315098300_CIT0027","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0883073808323027","article-title":"Segmental spinal myoclonus and metastatic cervical ganglioglioma: an unusual association","volume":"24","author":"Massimi","year":"2009","journal-title":"J Child Neurol."},{"issue":"11","key":"2025122607315098300_CIT0028","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1212\/WNL.42.11.2193","article-title":"Ataxia in epidural spinal cord compression","volume":"42","author":"Hainline","year":"1992","journal-title":"Neurology."},{"issue":"4","key":"2025122607315098300_CIT0029","first-page":"1","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurology(R) Neuroimmunol Neuroinflam"},{"issue":"6","key":"2025122607315098300_CIT0030","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","article-title":"Update on opsoclonus-myoclonus syndrome in adults","volume":"266","author":"Oh","year":"2019","journal-title":"J Neurol."},{"issue":"Pt 7","key":"2025122607315098300_CIT0031","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain."},{"key":"2025122607315098300_CIT0032","doi-asserted-by":"crossref","first-page":"120014","DOI":"10.1016\/j.jns.2021.120014","article-title":"Parkinsonism in viral, paraneoplastic, and autoimmune diseases","volume":"433","author":"Xing","year":"2022","journal-title":"J Neurol Sci."},{"key":"2025122607315098300_CIT0033","doi-asserted-by":"crossref","first-page":"829076","DOI":"10.3389\/fneur.2022.829076","article-title":"Autoimmune and paraneoplastic chorea: a review of the literature","volume":"13","author":"Kyle","year":"2022","journal-title":"Front Neurol."},{"issue":"11","key":"2025122607315098300_CIT0034","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s00415-011-6074-1","article-title":"Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience","volume":"258","author":"Vigliani","year":"2011","journal-title":"J Neurol."},{"issue":"8","key":"2025122607315098300_CIT0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2014-309201","article-title":"Stiff-person syndrome: insights into a complex autoimmune disorder","volume":"86","author":"Baizabal-Carvallo","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"6","key":"2025122607315098300_CIT0036","doi-asserted-by":"crossref","first-page":"448","DOI":"10.5761\/atcs.cr.21-00052","article-title":"Thymoma-related stiff-person syndrome with successfully treated by surgery","volume":"28","author":"Sasaki","year":"2022","journal-title":"Ann Thorac Cardiovasc Surg."},{"issue":"20","key":"2025122607315098300_CIT0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222010911","article-title":"The association of ovarian teratoma and Anti-N-Methyl-D-Aspartate Receptor Encephalitis: an updated integrative review","volume":"22","author":"Wu","year":"2021","journal-title":"Int J Mol Sci ."},{"issue":"1","key":"2025122607315098300_CIT0038","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol."},{"issue":"3","key":"2025122607315098300_CIT0039","first-page":"67","article-title":"Paraneoplastic neurologic disorders","volume":"23","author":"Gilligan","year":"2023","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"8","key":"2025122607315098300_CIT0040","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"2025122607315098300_CIT0041","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fimmu.2020.00991","article-title":"Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications","volume":"11","author":"Yshii","year":"2020","journal-title":"Front Immunol."},{"issue":"10","key":"2025122607315098300_CIT0042","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2169\/internalmedicine.5934-20","article-title":"Paraneoplastic cerebellar degeneration and Lambert-Eaton Myasthenic Syndrome with SOX-1 antibodies","volume":"60","author":"Wada","year":"2021","journal-title":"Intern Med."},{"issue":"2","key":"2025122607315098300_CIT0043","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1212\/NXI.0000000000000963","article-title":"Paraneoplastic cerebellar degeneration: the importance of including CDR2L as a diagnostic marker","volume":"8","author":"Herdlev\u00e6r","year":"2021","journal-title":"Neurology(R) Neuroimmunol Neuroinflam"},{"issue":"2","key":"2025122607315098300_CIT0044","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","article-title":"Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease","volume":"60","author":"Bernal","year":"2003","journal-title":"Neurology."},{"issue":"4","key":"2025122607315098300_CIT0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","article-title":"Clinical and immunological features of Opsoclonus-Myoclonus Syndrome in the era of neuronal cell surface antibodies","volume":"73","author":"Armangu\u00e9","year":"2016","journal-title":"JAMA Neurol"},{"issue":"3","key":"2025122607315098300_CIT0046","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1212\/NXI.0000000000001153","article-title":"Diagnosis and management of Opsoclonus-Myoclonus-Ataxia Syndrome in children: an international perspective","volume":"9","author":"Rossor","year":"2022","journal-title":"Neurol(R) Neuroimmunol Neuroinflam"},{"issue":"5","key":"2025122607315098300_CIT0047","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/adc.2010.204792","article-title":"Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome","volume":"97","author":"Brunklaus","year":"2012","journal-title":"Arch Dis Child."},{"issue":"11","key":"2025122607315098300_CIT0048","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","article-title":"Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"20","author":"Grativvol","year":"2018","journal-title":"Curr Oncol Rep."},{"issue":"Pt 8","key":"2025122607315098300_CIT0049","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain."},{"issue":"7","key":"2025122607315098300_CIT0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.nrl.2013.10.007","article-title":"Chorea secondary to striatal encephalitis due to anti-CV2\/CRMP5 antibodies. Case description and review of the literature","volume":"30","author":"Crespo-Burillo","year":"2015","journal-title":"Neurologia."},{"key":"2025122607315098300_CIT0051","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5334\/tohm.316","article-title":"Clinical spectrum of stiff person syndrome: a review of recent reports","volume":"6","author":"Sarva","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"4","key":"2025122607315098300_CIT0052","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/mds.25354","article-title":"The spectrum of movement disorders in children with anti-NMDA receptor encephalitis","volume":"28","author":"Baizabal-Carvallo","year":"2013","journal-title":"Mov Disord."},{"issue":"1","key":"2025122607315098300_CIT0053","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/practneurol-2021-003073","article-title":"Paraneoplastic neurological syndromes: a practical approach to diagnosis and management","volume":"22","author":"Binks","year":"2022","journal-title":"Pract Neurol."},{"key":"2025122607315098300_CIT0054","first-page":"5269352","article-title":"Anti-NMDAR-positive small-cell lung cancer paraneoplastic limbic encephalitis: a case report and literature review","volume":"2020","author":"Sohal","year":"2020","journal-title":"Case Rep Neurol Med"},{"issue":"24","key":"2025122607315098300_CIT0055","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2169\/internalmedicine.8400-21","article-title":"Radiation-induced brain calcification leads to L-dopa-resistant Parkinsonism and Cerebellar Ataxia","volume":"61","author":"Shimada","year":"2022","journal-title":"Intern Med."},{"key":"2025122607315098300_CIT0056","doi-asserted-by":"crossref","first-page":"916","DOI":"10.12659\/AJCR.900537","article-title":"Three cases of levodopa-resistant Parkinsonism after radiation therapy","volume":"17","author":"Mehanna","year":"2016","journal-title":"Am J Case Rep"},{"issue":"6","key":"2025122607315098300_CIT0057","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1212\/WNL.39.6.789","article-title":"Radiation-induced dementia in patients cured of brain metastases","volume":"39","author":"DeAngelis","year":"1989","journal-title":"Neurology."},{"issue":"Suppl","key":"2025122607315098300_CIT0058","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3171\/sup.2006.105.7.235","article-title":"Unilateral Holmes tremor and focal dystonia after Gamma Knife surgery","volume":"105","author":"Chiou","year":"2006","journal-title":"J Neurosurg."},{"issue":"1","key":"2025122607315098300_CIT0059","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/RLU.0000000000002729","article-title":"Brain 123I-FP-CIT SPECT of a Holmes Tremor due to midbrain pilocytic astrocytoma","volume":"45","author":"Louarn","year":"2020","journal-title":"Clin Nucl Med."},{"issue":"1","key":"2025122607315098300_CIT0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.20271","article-title":"Isolated tongue tremor after gamma knife radiosurgery for acoustic schwannoma","volume":"20","author":"Chung","year":"2005","journal-title":"Movement Disord"},{"issue":"4","key":"2025122607315098300_CIT0061","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mds.870020410","article-title":"Torticollis following radiation therapy","volume":"2","author":"Landan","year":"1987","journal-title":"Movement Disord"},{"issue":"3","key":"2025122607315098300_CIT0062","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nrl.2012.05.001","article-title":"Diston\u00eda oromandibular secundaria a radioterapia: descripci\u00f3n de 2 casos.","volume":"29","author":"Salazar","year":"2014","journal-title":"Neurolog\u00eda"},{"issue":"1","key":"2025122607315098300_CIT0063","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000346932","article-title":"Dystonia in a patient with melanoma metastatic to the brain treated with high-dose Interleukin-2, radiation therapy, and levetiracetam","volume":"6","author":"Sreenivasan","year":"2013","journal-title":"Case Rep Oncol"},{"issue":"3","key":"2025122607315098300_CIT0064","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mds.10330","article-title":"Late delayed postradiation spinal myoclonus or psychogenic movement disorder?","volume":"18","author":"L\u00f6scher","year":"2003","journal-title":"Movement Disord"},{"issue":"6","key":"2025122607315098300_CIT0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000116293","article-title":"Postradiation segmental myoclonus selectively inhibited by REM Sleep (Sleep-Wake Myoclonus)","volume":"28","author":"Askenasy","year":"1988","journal-title":"Eur Neurol."},{"issue":"3","key":"2025122607315098300_CIT0066","doi-asserted-by":"crossref","first-page":"158","DOI":"10.14802\/jmd.17023","article-title":"Spinal myoclonus responding to continuous intrathecal morphine pump","volume":"10","author":"Ahn","year":"2017","journal-title":"J Mov Disord"},{"issue":"5","key":"2025122607315098300_CIT0067","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00280-008-0876-6","article-title":"Central and peripheral nervous system toxicity of common chemotherapeutic agents","volume":"63","author":"Sioka","year":"2009","journal-title":"Cancer Chemother Pharmacol."},{"key":"2025122607315098300_CIT0068","doi-asserted-by":"crossref","first-page":"112371","DOI":"10.1016\/j.colsurfb.2022.112371","article-title":"Doxorubicin induced aggregation of \u03b1-synuclein: Insights into the mechanism of drug induced Parkinsonism","volume":"212","author":"Garg","year":"2022","journal-title":"Colloids Surf B Biointerfaces."},{"issue":"5","key":"2025122607315098300_CIT0069","first-page":"124","article-title":"A Parkinson-like syndrome as side effect of chemotherapy with vincristine and adriamycin in a child with acute leukaemia","volume":"31","author":"Boranic","year":"1979","journal-title":"Biomedicine"},{"issue":"7903","key":"2025122607315098300_CIT0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(75)91344-6","article-title":"Letter: Neurotoxicity of 5-fluorouracil","volume":"305","author":"Bergevin","year":"1975","journal-title":"The Lancet"},{"issue":"24","key":"2025122607315098300_CIT0071","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1212\/01.wnl.0000310642.97722.c8","article-title":"Reversible Parkinsonism and ataxia associated with high-dose octreotide","volume":"70","author":"Espay","year":"2008","journal-title":"Neurology."},{"issue":"3","key":"2025122607315098300_CIT0072","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mds.10344","article-title":"Chemotherapy-induced parkinsonism responsive to levodopa: An underrecognized entity","volume":"18","author":"Chuang","year":"2003","journal-title":"Mov Disord."},{"issue":"3","key":"2025122607315098300_CIT0073","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00007611-199703000-00022","article-title":"Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma","volume":"90","author":"Fleming","year":"1997","journal-title":"South Med J."},{"issue":"3","key":"2025122607315098300_CIT0074","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.870020309","article-title":"Parkisonism induced by high-dose cytosine arabinoside","volume":"2","author":"Luque","year":"1987","journal-title":"Mov Disord."},{"issue":"8","key":"2025122607315098300_CIT0075","first-page":"884","article-title":"Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma","volume":"18","author":"\u00d6zistanbullu","year":"2020","journal-title":"J Dtsch Dermatol Ges."},{"issue":"Suppl 3","key":"2025122607315098300_CIT0076","first-page":"S7","article-title":"Immune checkpoint inhibitor-associated striatal encephalitis presenting with subacute progressive Parkinsonism","volume":"10","author":"Prasertpan","year":"2023","journal-title":"Mov Disord Clin Pract"},{"issue":"12","key":"2025122607315098300_CIT0077","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41591-021-01564-7","article-title":"Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy","volume":"27","author":"Van Oekelen","year":"2021","journal-title":"Nat Med."},{"issue":"14","key":"2025122607315098300_CIT0078","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.2023020571","article-title":"Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells","volume":"142","author":"Karschnia","year":"2023","journal-title":"Blood."},{"issue":"2","key":"2025122607315098300_CIT0079","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1005791623733","article-title":"Focal dystonia after chemotherapy: a case series","volume":"34","author":"Brashear","year":"1997","journal-title":"J Neurooncol."},{"issue":"3","key":"2025122607315098300_CIT0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JOP.2017.021543","article-title":"Capecitabine-related neurotoxicity presenting as oromandibular dystonia","volume":"14","author":"Cengiz","year":"2018","journal-title":"J Oncol Pract"},{"issue":"6","key":"2025122607315098300_CIT0081","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/02841860701721785","article-title":"Capecitabine-induced oromandibular dystonia: a case report and literature review","volume":"47","author":"Ngeow","year":"2008","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"issue":"1","key":"2025122607315098300_CIT0082","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/02841869409098387","article-title":"Prednimustine-induced myoclonus\u2014a report of three cases","volume":"33","author":"Martin","year":"1994","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"issue":"2","key":"2025122607315098300_CIT0083","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/106002809703100207","article-title":"Myoclonus due to chlorambucil in two adults with lymphoma","volume":"31","author":"Wyllie","year":"1997","journal-title":"Ann Pharmacother."},{"issue":"9","key":"2025122607315098300_CIT0084","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-011-5990-4","article-title":"Ifosfamide associated myoclonus-encephalopathy syndrome","volume":"258","author":"Savica","year":"2011","journal-title":"J Neurol."},{"issue":"12","key":"2025122607315098300_CIT0085","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/bloodadvances.2019000249","article-title":"Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review","volume":"3","author":"Rhee","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"2025122607315098300_CIT0086","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1345\/aph.18425","article-title":"Fluorouracil-induced neurotoxicity","volume":"34","author":"Pirzada","year":"2000","journal-title":"Ann Pharmacother."},{"issue":"2","key":"2025122607315098300_CIT0087","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/1078155217739686","article-title":"Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment","volume":"25","author":"Godinho","year":"2019","journal-title":"J Oncol Pharm pract"},{"issue":"253","key":"2025122607315098300_CIT0088","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/adc.47.253.344","article-title":"Encephalopathy in acute leukaemia associated with methotrexate therapy","volume":"47","author":"Kay","year":"1972","journal-title":"Arch Dis Child."},{"issue":"7","key":"2025122607315098300_CIT0089","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jnnp-2020-323055","article-title":"Central nervous system complications associated with immune checkpoint inhibitors","volume":"91","author":"Vogrig","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"2025122607315098300_CIT0090","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/ene.15624","article-title":"Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review","volume":"30","author":"Dinoto","year":"2023","journal-title":"Eur J Neurol."},{"issue":"10","key":"2025122607315098300_CIT0091","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/SMJ.0b013e3181b66b28","article-title":"Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report","volume":"102","author":"Bota","year":"2009","journal-title":"South Med J."},{"key":"2025122607315098300_CIT0092","first-page":"2548528","article-title":"Nivolumab-induced autoimmune encephalitis in two patients with lung adenocarcinoma","volume":"2018","author":"Shah","year":"2018","journal-title":"Case Rep Neurol Med"},{"issue":"8","key":"2025122607315098300_CIT0093","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/WNL.0000000000007971","article-title":"Phosphodiesterase 10A IgG: a novel biomarker of paraneoplastic neurologic autoimmunity","volume":"93","author":"Zekeridou","year":"2019","journal-title":"Neurology."},{"issue":"1","key":"2025122607315098300_CIT0094","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13256-018-1786-9","article-title":"Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report","volume":"12","author":"Kopeck\u00fd","year":"2018","journal-title":"J Med Case Rep."},{"issue":"1","key":"2025122607315098300_CIT0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.psym.2020.08.010","article-title":"Case report of Akathisia in a patient with metastatic renal cell carcinoma on nivolumab","volume":"62","author":"Ho","year":"2021","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"2025122607315098300_CIT0096","doi-asserted-by":"crossref","first-page":"880","DOI":"10.12659\/AJCR.900941","article-title":"Nivolumab-induced severe akathisia in an advanced lung cancer patient","volume":"17","author":"Abe","year":"2016","journal-title":"Am J Case Rep"},{"issue":"4","key":"2025122607315098300_CIT0097","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ajhg.2016.03.015","article-title":"Biallelic mutations in PDE10A lead to loss of striatal PDE10A and a hyperkinetic movement disorder with onset in infancy","volume":"98","author":"Diggle","year":"2016","journal-title":"Am J Hum Genet."},{"key":"2025122607315098300_CIT0098","doi-asserted-by":"crossref","first-page":"744823","DOI":"10.3389\/fimmu.2021.744823","article-title":"Advances in universal CAR-T cell therapy","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol."},{"issue":"1","key":"2025122607315098300_CIT0099","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/head.12712","article-title":"Movement disorders from the use of metoclopramide and other antiemetics in the treatment of migraine","volume":"56","author":"Wijemanne","year":"2016","journal-title":"Headache."},{"issue":"9","key":"2025122607315098300_CIT0100","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1474-4422(19)30152-8","article-title":"Recent developments in drug-induced movement disorders: a mixed picture","volume":"18","author":"Factor","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"2025122607315098300_CIT0101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/medicina61010131","article-title":"Drug-induced myoclonus: a systematic review","volume":"61","author":"Rissardo","year":"2025","journal-title":"Medicina (Kaunas)"},{"volume-title":"Increased Intracranial Pressure","year":"2024","author":"Pinto","key":"2025122607315098300_CIT0102"},{"issue":"8","key":"2025122607315098300_CIT0103","doi-asserted-by":"crossref","first-page":"e3151","DOI":"10.1002\/brb3.3151","article-title":"Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment","volume":"13","author":"Cedergren Weber","year":"2023","journal-title":"Brain Behav"},{"issue":"1","key":"2025122607315098300_CIT0104","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6004\/jnccn.2023.0002","article-title":"NCCN Guidelines\u00ae Insights: Central Nervous System Cancers, Version 2.2022","volume":"21","author":"Horbinski","year":"2023","journal-title":"J Nat Comprehensive Cancer Network : JNCCN"},{"issue":"4","key":"2025122607315098300_CIT0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3171\/jns.1984.61.4.0649","article-title":"Thalamic tumors in children","volume":"61","author":"Bernstein","year":"1984","journal-title":"J Neurosurg."},{"issue":"36","key":"2025122607315098300_CIT0106","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol."},{"issue":"4","key":"2025122607315098300_CIT0107","doi-asserted-by":"crossref","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","article-title":"Management of immunotherapy-related toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Thompson","year":"2022","journal-title":"J Natl Compr Canc Netw."},{"issue":"14","key":"2025122607315098300_CIT0108","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood.2023021429","article-title":"Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity","volume":"142","author":"Graham","year":"2023","journal-title":"Blood."},{"issue":"4","key":"2025122607315098300_CIT0109","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/j.prro.2014.12.001","article-title":"Should we irradiate a brain tumor in a patient with parkinsonism? A case report and literature review","volume":"5","author":"Engelman","year":"2015","journal-title":"Pract Radiat Oncol"}],"container-title":["Neuro-Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nop\/advance-article-pdf\/doi\/10.1093\/nop\/npaf062\/63498637\/npaf062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/12\/6\/970\/63498637\/npaf062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/12\/6\/970\/63498637\/npaf062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T12:32:14Z","timestamp":1766752334000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nop\/article\/12\/6\/970\/8163689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":109,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,16]]},"published-print":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/nop\/npaf062","relation":{},"ISSN":["2054-2577","2054-2585"],"issn-type":[{"type":"print","value":"2054-2577"},{"type":"electronic","value":"2054-2585"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,6,16]]}}}